Preparing for FDA’s 2026 Human Foods Priorities: Transparency is the New Flavor
02/03/2026
What the Human Foods Agenda Means for Regulated Businesses
What the Human Foods Agenda Means for Regulated Businesses
Last week, FDA announced an Immediate National Strategy to Increase the Resiliency of the U.S. Infant Formula Market. The strategy is a result of shake-up caused by the
Will FDA’s Recognition of System Vulnerabilities in its Infant Formula Response Open the Door for Alternative Supply Sources and Regulatory Changes?
